Sanofi India Company Description

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors.

It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012.

The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

Sanofi India Limited

Country	India
Founded	1956
Industry	Drug Manufacturers - General
Sector	Healthcare
Employees	2,174
CEO	Rodolfo Hrosz

Contact Details

Address: Sanofi House Mumbai, 400072 India
Phone	91 22 2803 2000
Website	sanofiindialtd.com

Stock Details

Ticker Symbol	SANOFI
Exchange	National Stock Exchange of India
Fiscal Year	January - December
Reporting Currency	INR
ISIN Number	INE058A01010
SIC Code	2834

Key Executives

Name	Position
Rodolfo Hrosz	MD and Director
Rachid Ayari	Chief Financial Officer and Whole Time Director
Renee Amonkar	Additional Whole Time Director
M. K. Narayanaswamy B.Com.,A.I.C.W.A.	Senior Director of Accounting and Taxation
Flovie Martins	Head of Corporate Communications and Corporate Social Responsibility
Surabhi Kaur	People and Culture Director
Sanjay V. Chavan	Head of Country Procurement - India
Nakul Verma	Senior Director of Public Affairs
Yasmin Shenoy	Senior Director of Regulatory Affairs
N. Suresh Babu	Sales and Customer Engagement Head - Diabetes and Senior Director of Diabetes